PATENT, EXPERTS – The Federal Circuit partially reversed a $7 million judgment against Abbott Laboratories for infringing on Innogenetics’ patented technology for finding and classifying hepatitis C virus genotypes in a biological sample. J. Moore found that expert testimony misunderstood the term “genotyping,” but that the failure to use the district court’s exact words did not change the substance of the testimony. See ruling.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.

